| Tag | Content |
|---|
EnhancerAtlas ID | HS003-08981 |
Organism | Homo sapiens |
Tissue/cell | A549 |
Coordinate | chr11:108486850-108488900 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr11:108488323-108488341 | GGGAAGAGGGAAGGAAGG | + | 7.21 | | ZNF263 | MA0528.1 | chr11:108488324-108488345 | GGAAGAGGGAAGGAAGGAGAA | + | 6.55 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_64978 | chr11:108486655-108489503 | NHEK |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH11I108614 | chr11 | 108485615 | 108489220 |
|
Enhancer Sequence | TACTTGGGAG GATAAGGTGG GAGAATAGCT GGAACCTGGG AGGCAGACCG AGCCAAGATC 60
ACGCTGCTGC ACTCCAGCCT GGGTGACAGA CAGAGACCCT GTCTCAAAAA ACAAAACAAA 120
ACCCAAAAAA CAAACGGGCC GGGCGCAGTG GCTCACACCT GTAATCCCAG CACTTTAGGA 180
GGCCCAGGTG GGTAGATAAC CCGAGGTCAG GAGTTCGAGA CCAGCCTGGC CGAGATGGTG 240
AAACCCCGTC TCTACTAAAA TTACAAAAAT TAGCTGGGCA CGGTGGCAGG AGCCTGTAAT 300
CCCAGCTACT CGGGAGGCTG AGGCAGGAGA ATCCCTTGAA CCAGGGTGGC AGAGATTGCA 360
GTGAGCTGAG ATCGAGCCAT TGCACTCCAG GCCGAGTGAT AGAGTGAGAC TCTGTCTCAA 420
AACAAAAAAA CAAAAAGCAA ATAATTCAGG CCCTTTGCTT TTGTCTATAT GTAGGTATGC 480
TGCCTATTAT TTACCTGAGA AGCAAAACAA ACTGGATATT CCAACTGAAA ATGTGACTGT 540
TATGACTCAT AATTCCTGCT GGATTTCAAA TCCTATTGTC TTATGATTAC CTCATTGGAG 600
TTGTGTGAAT CACCTTGTCT TCCGTGCGTT GACTAACTAG AAAGAACCTC CTGGTTTCTC 660
CTGAGAGATT GCTTTCTTTT TGTTGTGGTC ACCATCACCA TGACACTGCA ATAGGGCGAT 720
CACATTCCAG AGCAGTGGAT GGTGTACTAA GCCAGGAGCC TGAATTAGGG ATAGCATAAT 780
TCCATCCTAT TCCTTAAATA TTAGGTGAGC AGCTACTCAG TGTAATGCTC AGTATAGTAC 840
TCCATGGTCT TTTAAAACTT TGCAACCTGG CAGAGGAGTA GAAAATGTAA GGGAACAGCT 900
GAAAAAATGG GCCAAGATAA AAGGTTTAAT CTTCAAACTT TCAGTGTTAA TCAAGCCCCT 960
CTTAAATTGA GATGAGGACT GACCTAAACA CAATTATTTT CCCTTTTTGG GATAGGAAAT 1020
CCTAAGACAG TTCCCAGGGC TTGAGGCTAT CACTAAGAGC TACTTAAGAG TTTCTGAACT 1080
ATAAGATCTG GCGTAATTAG CCAGGCGTGG TGGCTGCCAG GGCCTGTAGT CTCAGCTAAT 1140
GGTGTGTGTT GTGGGGAGTG AGAGGATAAG GAGGGAGGAT GGAATTGTTT GAGCCAGGGA 1200
GTTCGAGGCT GCAGTGAGCT ATGGTTGGGG GCCCCTGCAC TCCAGCCTGG GCGACAGAGT 1260
TGAGACCCAA GATCCAGTCT ACATCCCTCA AATTTTTCAT GATGCCCAAT GTTTTCCTTT 1320
GTAAGCAGGG CTTAGATTCC AAATAGATTC CACTAAAACT GTGAATGAGA AACAAGGCAA 1380
AGTCTTGTTC TCCTTCTCCA GTGTGTTCCC CTCAATGCTC TAAGAGCATT ATTTGTTAAT 1440
GGAACATCAT GTTTGGGTAC AAGGGGAGGC GAAGGGAAGA GGGAAGGAAG GAGAAGGCAA 1500
GGAGGATGAC TAAAGGTACT TCAGTGGTTC AGAAAGAGGT AGAAGATTTA CCTGTTGGCT 1560
ACTGCCTTGT TAGCCTACTA GATGCAGATG CTGTTTGTGG GCAGGAAAAG CTTGTCATCT 1620
TGCAAAGGTG CACAGGAGGC AAGACTTTTT TTTCCCTATG TCCTTTCTGT ATTTTCTGTT 1680
AACACCAGAT GCACACCAGA GATGTTCTAA GCAGGTTAAA AGTGGCTTGG GATTATATCT 1740
GATTAGCAAA GAGTTAATGA ATTTGTGGCA AAATTCTGAG TGAATTAAAA AAGAAAGTCA 1800
GCTGCAGCAT AAGCTTCCTA AGCCACTTAT GCAGGATGCT TAAGGACAGT CTAACCTGTT 1860
AGAGAATCAT TACAAGGTAT ATACCACTCT ATCCCTTTCC TTACCTCTTG TAAGCTTCTG 1920
TGGCATAATG AGACTTCATG TTTATTTTAG TGTATATATT TGTTGGAGTT ACTAATAAAA 1980
TAAGAAATTA AAAGAGAACA TTTTTAAAAA ATTCAGATAC GTTTGAATAG ACAAAAGAAA 2040
GAGGCATTTG 2050
|
